drugset
drugset / Trial / NCT01652742

Study to Explore Pharmacokinetics and Pharmacodynamics of a Single Rising Dose of BI 135585 XX

NCT01652742 ↗

Phase 1 Completed 9 enrolled Boehringer Ingelheim
NaSingle-groupOpen-labelTreatment

Summary

To investigate the pharmacokinetics and pharmacodynamics of BI 135585 XX following single dose administration.

Timeline

Start
2012-07
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 135585 XX Unknown — Oral

Indications

No indication recorded.